Uzansertib

DB17571InvestigationalSmall molecule

Uzansertib is under investigation in clinical trial NCT02587598 (Study of INCB053914 in Subjects With Advanced Malignancies).

Mechanism: Pharmacologically active on Serine/threonine-protein kinase pim-1, Serine/threonine-protein kinase pim-3, and Serine/threonine-protein kinase pim-2
Curator reviewed
Also known as: INCB053914

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Uzansertib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.